Black Rock Inc. Enzo Biochem Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Enzo Biochem Inc stock. As of the latest transaction made, Black Rock Inc. holds 955,023 shares of ENZ stock, worth $678,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

955,023

Previous 953,991 0.11%

Holding current value

$678,066

Previous $1.21 Million 14.12%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.04 - $1.28 $1,073 - $1,320	1,032 Added 0.11%	955,023 $1.04 Million
Q1 2024 May 10, 2024	BUY	$1.21 - $1.5 $392 - $486	324 Added 0.03%	953,991 $1.21 Million
Q4 2023 Feb 13, 2024	SELL	$1.21 - $1.44 $2,089 - $2,486	-1,727 Reduced 0.18%	953,667 $1.33 Million
Q3 2023 Nov 13, 2023	SELL	$1.3 - $1.87 $56,010 - $80,568	-43,085 Reduced 4.32%	955,394 $1.34 Million
Q2 2023 Aug 11, 2023	SELL	$1.84 - $2.66 $776,312 - $1.12 Million	-421,909 Reduced 29.7%	998,479 $1.84 Million
Q1 2023 May 12, 2023	SELL	$1.0 - $2.51 $5,419 - $13,601	-5,419 Reduced 0.38%	1,420,388 $3.45 Million
Q4 2022 Feb 13, 2023	SELL	$1.16 - $2.42 $49,084 - $102,399	-42,314 Reduced 2.88%	1,425,807 $2.04 Million
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.73 $130,481 - $169,625	-62,134 Reduced 4.06%	1,468,121 $3.28 Million
Q2 2022 Aug 12, 2022	SELL	$2.0 - $3.0 $20,672 - $31,008	-10,336 Reduced 0.67%	1,530,255 $3.17 Million
Q1 2022 May 12, 2022	BUY	$2.9 - $3.47 $21,518 - $25,747	7,420 Added 0.48%	1,540,591 $4.47 Million
Q4 2021 Feb 10, 2022	BUY	$3.17 - $4.09 $3,173 - $4,094	1,001 Added 0.07%	1,533,171 $4.92 Million
Q3 2021 Nov 09, 2021	SELL	$3.01 - $3.77 $54,827 - $68,670	-18,215 Reduced 1.17%	1,532,170 $5.42 Million
Q2 2021 Aug 11, 2021	BUY	$2.86 - $3.61 $4.43 Million - $5.6 Million	1,550,385 New	1,550,385 $4.92 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.5M

Call Options Held

2.3K

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $34.6M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account